SCINTIGRAPHY OF RENAL-CELL CARCINOMA WITH I-131-LABELED MONOCLONAL-ANTIBODY (MAB) G250

被引：0
|
作者：
DIVGI, CR [1 ]
OOSTERWIJK, E [1 ]
SCOTT, AM [1 ]
BANDER, N [1 ]
OOSTERWIJK, J [1 ]
WELT, S [1 ]
LARSON, SM [1 ]
OLD, LJ [1 ]
机构：
[1] MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1992年 / 19卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：576 / 576
页数：1
相关论文
共 50 条
  • [1] RADIOLABELED MONOCLONAL-ANTIBODY G250 IN RENAL-CELL CARCINOMA
    OOSTERWIJK, E
    DEBRUYNE, FMJ
    [J]. WORLD JOURNAL OF UROLOGY, 1995, 13 (03) : 186 - 190
  • [2] THE USE OF MONOCLONAL-ANTIBODY G250 IN THE THERAPY OF RENAL-CELL CARCINOMA
    OOSTERWIJK, E
    DEBRUYNE, FMJ
    SCHALKEN, JA
    [J]. SEMINARS IN ONCOLOGY, 1995, 22 (01) : 34 - 41
  • [3] RADIOIMMUNOTHERAPY (RIT) WITH I-131 MONOCLONAL-ANTIBODY (MAB) G250 IN METASTATIC RENAL-CANCER
    DIVGI, CR
    BANDER, NH
    GRAHAM, MC
    SCOTT, AM
    WELT, S
    MOTZER, RJ
    OOSTERWIJK, E
    LARSON, SM
    OLD, LJ
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P101 - P101
  • [4] Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250
    Steffens, MG
    Boerman, OC
    OosterwijkWakka, JC
    Oosterhof, GON
    Witjes, JA
    Koenders, EB
    Oyen, WJG
    Buijs, WCAM
    Debruyne, FMJ
    Corstens, FHM
    Oosterwijk, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (04) : 1529 - 1537
  • [5] Radioimmunotargeting with I-131 labeled chimeric G250 monoclonal antibody in patients with renal cell carcinoma.
    Steffens, MG
    Boerman, OC
    Oosterwijk, E
    Oosterhof, GON
    Witjes, JA
    OosterwijkWakka, JC
    Koenders, E
    Debruyne, FMJ
    Corstens, FHM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 740 - 740
  • [6] Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250
    Steffens, MG
    Boerman, OC
    de Mulder, PHM
    Oyen, WJG
    Buijs, WCAM
    Witjes, JA
    van den Broek, WJM
    Oosterwijk-Wakka, JC
    Debruyne, FMJ
    Corstens, FHM
    Oosterwijk, E
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (10) : 3268S - 3274S
  • [7] Fractionated radioimmunotherapy with I-131-labeled chimeric antibody G250 (cG250) in patients with metastatic renal cell carcinoma.
    Divgi, CR
    O'Donoghue, JA
    McGagh, DA
    Motzer, RJ
    Anwar, K
    Sheikh, A
    Gonzalez, RS
    Welt, S
    Old, LJ
    Larson, SM
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 217P - 217P
  • [8] Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma
    Divgi, CR
    Bander, NH
    Scott, AM
    O'Donoghue, JA
    Sgouros, G
    Welt, S
    Finn, RD
    Morrissey, F
    Capitelli, P
    Williams, JM
    Deland, D
    Nakhre, A
    Oosterwijk, E
    Gulec, S
    Graham, MC
    Larson, SM
    Old, LJ
    [J]. CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2729 - 2739
  • [9] Targeting of metastatic renal cell carcinoma with the chimeric monoclonal antibody G250 labeled with 131I or 111In:: An intrapatient comparison
    Brouwers, AH
    Buijs, WCAM
    Oosterwijk, E
    Boerman, OC
    Mala, C
    De Mulder, PHM
    Corstens, FHM
    Mulders, PFA
    Oyen, WJG
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (10) : 3953S - 3960S
  • [10] LOCALIZATION OF MONOCLONAL ANTIBODY-G250 AND BISPECIFIC MONOCLONAL-ANTIBODY CD3/G250 IN HUMAN RENAL-CELL CARCINOMA XENOGRAFTS - RELATIVE EFFECTS OF SIZE AND AFFINITY
    VANDIJK, J
    ZEGVELD, ST
    FLEUREN, GJ
    WARNAAR, SO
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (05) : 738 - 743
12345